These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 9649707)

  • 1. Pathogenesis of leukocytoclastic vasculitis.
    Claudy A
    Eur J Dermatol; 1998 Mar; 8(2):75-9. PubMed ID: 9649707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Physiopathology of leukocytoclastic vasculitis].
    Claudy A
    Ann Dermatol Venereol; 1998 Nov; 125(11):791-6. PubMed ID: 9856261
    [No Abstract]   [Full Text] [Related]  

  • 3. P-selectin glycoprotein ligand-1 is required for the development of cutaneous vasculitis induced by immune complex deposition.
    Yanaba K; Komura K; Horikawa M; Matsushita Y; Takehara K; Sato S
    J Leukoc Biol; 2004 Aug; 76(2):374-82. PubMed ID: 15123773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenesis of vascular inflammation by anti-neutrophil cytoplasmic antibodies.
    Jennette JC; Xiao H; Falk RJ
    J Am Soc Nephrol; 2006 May; 17(5):1235-42. PubMed ID: 16624929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased membrane expression of proteinase 3 during neutrophil adhesion in the presence of anti proteinase 3 antibodies.
    Brachemi S; Mambole A; Fakhouri F; Mouthon L; Guillevin L; Lesavre P; Halbwachs-Mecarelli L
    J Am Soc Nephrol; 2007 Aug; 18(8):2330-9. PubMed ID: 17634439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Leukocytoclastic vasculitis. New physiopathologic concepts].
    Claudy AL
    Ann Dermatol Venereol; 1990; 117(5):419-22. PubMed ID: 2205146
    [No Abstract]   [Full Text] [Related]  

  • 7. Site of blood vessel damage and relevance of CD18 in a murine model of immune complex-mediated vasculitis.
    Sindrilaru A; Seeliger S; Ehrchen JM; Peters T; Roth J; Scharffetter-Kochanek K; Sunderkötter CH
    J Invest Dermatol; 2007 Feb; 127(2):447-54. PubMed ID: 17008881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative study of the immunopathology of skin lesions and circulating immune complexes in leucocytoclastic vasculitis (Gougerot-Ruiter's disease) (author's transl)].
    Gomes MA; Dambuyant C; Fernandez-Bussy R; Thivolet J
    Ann Dermatol Venereol; 1982; 109(1):35-41. PubMed ID: 7041772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathophysiology of ANCA-associated vasculitides: are ANCA really pathogenic?
    Tervaert JW; Heeringa P
    Neth J Med; 2003 Dec; 61(12):404-7. PubMed ID: 15025415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune complexes in the reactive inflammatory vascular dermatoses.
    Jegasothy BV
    Dermatol Clin; 1985 Jan; 3(1):185-90. PubMed ID: 3912088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coexpression of CD177 and membrane proteinase 3 on neutrophils in antineutrophil cytoplasmic autoantibody-associated systemic vasculitis: anti-proteinase 3-mediated neutrophil activation is independent of the role of CD177-expressing neutrophils.
    Hu N; Westra J; Huitema MG; Bijl M; Brouwer E; Stegeman CA; Heeringa P; Limburg PC; Kallenberg CG
    Arthritis Rheum; 2009 May; 60(5):1548-57. PubMed ID: 19404956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutrophil activation in anti-proteinase 3-positive vasculitis--a prospective study.
    Wikman A; Lundahl J; Jacobson SH
    Scand J Immunol; 2005 Dec; 62(6):539-45. PubMed ID: 16316421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The importance of resolution of inflammation in the pathogenesis of ANCA-associated vasculitis.
    Harper L; Williams JM; Savage CO
    Biochem Soc Trans; 2004 Jun; 32(Pt3):502-6. PubMed ID: 15157172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of rolling neutrophils with antineutrophil cytoplasmic antibodies causes conversion to firm integrin-mediated adhesion.
    Radford DJ; Savage CO; Nash GB
    Arthritis Rheum; 2000 Jun; 43(6):1337-45. PubMed ID: 10857792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of myeloperoxidase in vasculitis development.
    Suzuki K; Okazaki T
    Jpn J Infect Dis; 2004 Oct; 57(5):S2-3. PubMed ID: 15507759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Translating basic science into patient therapy for ANCA-associated small vessel vasculitis.
    Williams JM; Kamesh L; Savage CO
    Clin Sci (Lond); 2005 Feb; 108(2):101-12. PubMed ID: 15504102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Vasculitis--aspect of cellular and molecular pathogenesis].
    Gröne HJ
    Verh Dtsch Ges Pathol; 2001; 85():142-52. PubMed ID: 11894391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human hypersensitivity angiitis.
    Sams WM
    Immunol Ser; 1989; 46():585-604. PubMed ID: 2535132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunotherapy for antineutrophil cytoplasmic antibody-associated vasculitis: challenging the therapeutic status quo?
    Bosch X; Guilabert A; Espinosa G; Mirapeix E
    Trends Immunol; 2008 Jun; 29(6):280-9. PubMed ID: 18440274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Free radicals and antioxidants: physiology, human pathology and therapeutic aspects (part II)].
    Sahnoun Z; Jamoussi K; Zeghal KM
    Therapie; 1998; 53(4):315-39. PubMed ID: 9806002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.